Clinical Trial

Natural History Study for Patients With Angelman Syndrome

Study acronym: NatHisAngelman
Recruiting
View on ClinicalTrials.gov →
Summary
This study is a 9-year natural history study for patients with Angelman syndrome in Belgium (a genetic neurodevelopmental disorder, affecting 500,000 individuals in the world). It includes a 3-year recruitment phase, a 5 year follow-up and a year to analyze the collected data. The investigators plan to include 30 patients with a semi-annual follow-up for 4 years. The investigators will collect relevant retrospective and prospective data using age-standardized scales and questionnaires for functional motor assessments and global developmental assessment.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2024-01-17; most recent amendment 2025-05-15.
Trial Details
NCT Number NCT06229769
Lead Sponsor Centre Hospitalier Universitaire de Liege
Collaborators: Centre Hospitalier Régional de la Citadelle, SYSNAV
Conditions Angelman Syndrome
Enrollment 30 participants
Start Date 2021-10-10
Primary Completion 2028-01 (estimated)
Study Completion 2028-01 (estimated)
Updated on ClinicalTrials.gov 2025-05-20